Searched for
BDR
BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution formIt is a more patient-friendly way to tackle prostate cancer. It can help improve patient compliance to a great extent, Badiger said. The co...- BDR Pharmaceutical launches generic drug for treating prostate cancer in IndiaBDR Group Director Business Development Raheel Shah said that the launch of APATIDE is "testimony towards our commitment in providing acces...
- BDR Pharma raises Rs 685 crore from multiples, other investorsThe consortium of investors participating along with Multiples include institutional investors such as the investment arm of Times Group, Q...
- BDR looking to buy majority stake in drug plant in BelarusBDR will be investing $13 million in the Belarus facility. In addition, it is also investing in setting up a formulation manufacturing unit...
- Multiples Alternate buys into BDR Pharma, invests Rs 750 crET was the first to report in July last year that global and domestic PE funds were in initial discussions to purchase a minority stake in ...
- Mankind, BDR Pharma join hands to launch anti COVID-19 pill MolulifeMankind Pharma on Wednesday said it has joined hands with BDR Pharmaceuticals to launch oral anti-COVID-19 pill Molulife (Molnupiravir) in ...
- Global private equity funds in talks to purchase minority stake in BDR PharmaceuticalsFunds like the Carlyle Group, Warburg Pincus and TA Associates are engaged in initial discussions, the people added. Investment bank O3 Cap...
- BDR Pharma launches generic cancer drug in IndiaBDR Pharmaceuticals on Wednesday said it has launched the generic version of Lenvatinib drug for the treatment of various types of cancers ...
- BDR Pharma launches 80 mg version of prostate cancer drug at Rs 24,480 per pack in IndiaThe company had earlier received approval from the Drugs Controller General of India (DCGI) to manufacture 40 mg enzalutamide in 2017 to tr...
- BDR Pharmaceuticals launches Favipiravir under brand name 'BDFAVI' at Rs 63 per tablet in IndiaBDR pharma has received an approval from the DCGI to manufacture Favipiravir to treat mild to moderate patients with COVID-19 symptoms. The...
- BDR in pact to make Gilead drug for CiplaIn late May, BDR had sought the approval of India’s drug regulator to make and sell remdesivir in India without entering into an arrangemen...
- Carlyle in talks to invest $100 million in BDR PharmaBDR clocked Rs 550-600 crore in revenue and around Rs 120 crore in FY18 EBITDA.
- Bangladesh court upholds death sentence of 139 BDR soldiersThe judgement comes four years after a lower court in Dhaka handed down capital punishment to 152 and life term to 158 soldiers of the BDR.
- Patent office rejects BDR Pharma’s compulsory licensing applicationThe Patent Office rejected BDR’s application on the grounds that the company did not make enough efforts to obtain a voluntary licence for ...
- BDR Pharmaceutical's plea for compulsory licence on cancer drug rejectedThe Indian Patent Office has rejected Mumbai-based BDR Pharmaceutical’s application for compulsory licence on cancer drug Dasatinib.
- BDR Pharma seeks cancer drug licenceBDR Pharma has filed an application with the Mumbai Patent Office, seeking compulsory licence to market a crucial cancer drug, dasatinib
- BDR trying to encroach on Indian land: BSFBDR has been obstructing Indian farmers from cultivating land, BSF said.
- BDR personnel missing from Indo-Bangla border postsBDR personnel have not been seen on Saturday along the Indo-Bangladesh border in the north east and were absent from the immigration posts ...
- Mass grave discovered at BDR headquarters, 30 bodies recoveredBangladeshi soldiers on Friday discovered a mass grave at the BDR complex here and recovered bodies of at least 30 Army officers, two days ...
- Brass wiped out, BDR-BSF talks may be put offAlmost the entire Bangladesh Rifles brass may have been wiped out.
Load More
